MONTREAL, QUEBEC--(Marketwire - June 12, 2008) - ZoomMed (TSX VENTURE: ZMD), developer of the “ZRx Prescriber” intended for physicians, is proud to announce that Boehringer Ingelheim, a pharmaceutical company, signed a renewal agreement, for the diffusion of information to physicians using the ZRx Prescriber.
